Merck to buy Acceleron for about $11.5 billion in rare disease drug push
(Reuters) -Merck & Co is buying Acceleron Pharma Inc for about $11.5 billion, broadening its portfolio beyond aging cancer drug
Read more(Reuters) -Merck & Co is buying Acceleron Pharma Inc for about $11.5 billion, broadening its portfolio beyond aging cancer drug
Read more